ABSTRACT Secondary bacterial infections increase disease severity of influenza virus infections and contribute greatly to increased morbidity and mortality during pandemics. To study secondary bacterial infection following influenza virus infection, mice were inoculated with sublethal doses of 2009 seasonal H1N1 virus (NIH50) or pandemic H1N1 virus (Mex09) followed by inoculation with Streptococcus pneumoniae 48 h later. Disease was characterized by assessment of weight loss and survival, titration of virus and bacteria by quantitative reverse transcription-PCR (qRT-PCR), histopathology, expression microarray, and immunohistochemistry. Mice inoculated with virus alone showed 100% survival for all groups. Mice inoculated with Mex09 plus S. p...
<div><p>The swine-origin H1N1 virus which emerged in 2009 resulted in the first influenza pandemic o...
Secondary bacterial infections are a leading cause of illness and death during epidemic and pandemic...
Aim. In this study we developed and characterized a mouse model of secondary S. aureus and S. pneumo...
Secondary Streptococcus pneumoniae infection after influenza is a significant clinical complication ...
Influenza is a leading cause of respiratory disease worldwide. During pandemic and seasonal influenz...
ABSTRACT Fatal outcomes following influenza infection are often associated with secondary bacterial ...
Background: Coinfection with influenza virus and bacteria is a major cause of high mortality during ...
Influenza A virus (IAV) and Streptococcus pneumoniae (S. pn.) are major causes of respiratory tract ...
Seasonal influenza epidemics pose a considerable hazard for global health. In the past decades, accu...
Influenza pneumonia causes high mortality every year, and pandemic episodes kill millions of people....
Influenza pneumonia causes high mortality every year, and pandemic episodes kill millions of people....
Co-infections of influenza virus and bacteria are known to cause severe disease, but little informat...
Secondary bacterial infections are a leading cause of illness and death during epidemic and pandemic...
Background: Influenza pneumonia causes high mortality every year, and pandemic episodes kill million...
The mechanisms of severe pneumonia caused by co-infection of bacteria and influenza A virus (IAV) ha...
<div><p>The swine-origin H1N1 virus which emerged in 2009 resulted in the first influenza pandemic o...
Secondary bacterial infections are a leading cause of illness and death during epidemic and pandemic...
Aim. In this study we developed and characterized a mouse model of secondary S. aureus and S. pneumo...
Secondary Streptococcus pneumoniae infection after influenza is a significant clinical complication ...
Influenza is a leading cause of respiratory disease worldwide. During pandemic and seasonal influenz...
ABSTRACT Fatal outcomes following influenza infection are often associated with secondary bacterial ...
Background: Coinfection with influenza virus and bacteria is a major cause of high mortality during ...
Influenza A virus (IAV) and Streptococcus pneumoniae (S. pn.) are major causes of respiratory tract ...
Seasonal influenza epidemics pose a considerable hazard for global health. In the past decades, accu...
Influenza pneumonia causes high mortality every year, and pandemic episodes kill millions of people....
Influenza pneumonia causes high mortality every year, and pandemic episodes kill millions of people....
Co-infections of influenza virus and bacteria are known to cause severe disease, but little informat...
Secondary bacterial infections are a leading cause of illness and death during epidemic and pandemic...
Background: Influenza pneumonia causes high mortality every year, and pandemic episodes kill million...
The mechanisms of severe pneumonia caused by co-infection of bacteria and influenza A virus (IAV) ha...
<div><p>The swine-origin H1N1 virus which emerged in 2009 resulted in the first influenza pandemic o...
Secondary bacterial infections are a leading cause of illness and death during epidemic and pandemic...
Aim. In this study we developed and characterized a mouse model of secondary S. aureus and S. pneumo...